Behavioural Economics-based Incentives in Adults With Type 2 Diabetes (BET2)
NCT ID: NCT04917926
Last Updated: 2024-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
122 participants
INTERVENTIONAL
2021-06-21
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Behavioural Economics-based Incentives in Adults With Type 2 Diabetes Pilot Study
NCT04443842
Behavioral Economics and Self-Determination Theory to Change Diabetes Risk (BEST Change)
NCT04902326
Behavioral Economic Incentives to Improve Glycemic Control Among Adolescents and Young Adults
NCT02568501
Social Incentives to Improve Diabetes
NCT02961192
Effectiveness of Motivational Interviewing on Improving Care for Patients With Type 2 Diabetes in China
NCT04342845
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This trial adopts a pragmatic study design based on the PRECIS-2 tool and RE-AIM frameworks.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Financial and social intervention
Participants will receive the usual standard care (same as control group), loss-framed financial incentives, social incentives and weekly feedback on performance for 6 months.
Financial and social incentives
Participants will be credited with HK$1,000 in their virtual accounts at the beginning of the trial. After baseline step counts are gathered in the second week, they will lose HK$40 for each subsequent week that they do not meet their personal weekly step target. Regarding social incentives, participants will be placed in teams of six, receiving feedback of their physical activity performance, rankings within their groups, and positive messages for encouragement. Nominated supporters will be informed of participants' performance for social support.
Control
Participants will receive standard care including patient screening and education on diet, physical activity, and smoking conducted by a multi-disciplinary team. Participants in the control group will neither be told their baseline step count nor receive any feedback messages.
No interventions assigned to this group
Financial intervention
Participants will receive the usual standard care (same as control group), loss-framed financial incentives, and weekly feedback on performance for 6 months.
Financial incentives
Participants will be credited with HK$1,000 in their virtual accounts at the beginning of the trial. After baseline step counts are gathered in the second week, they will lose HK$40 for each subsequent week that they do not meet their personal weekly step target.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Financial and social incentives
Participants will be credited with HK$1,000 in their virtual accounts at the beginning of the trial. After baseline step counts are gathered in the second week, they will lose HK$40 for each subsequent week that they do not meet their personal weekly step target. Regarding social incentives, participants will be placed in teams of six, receiving feedback of their physical activity performance, rankings within their groups, and positive messages for encouragement. Nominated supporters will be informed of participants' performance for social support.
Financial incentives
Participants will be credited with HK$1,000 in their virtual accounts at the beginning of the trial. After baseline step counts are gathered in the second week, they will lose HK$40 for each subsequent week that they do not meet their personal weekly step target.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Capable of providing informed consent
* Resident in Hong Kong
* Able to communicate in English or Chinese
* Diagnosed with type 2 diabetes within past year
* 6.5% ≤ HbA1c ≤ 9.0%
* Willing to take blood tests
* Access to a phone to track physical activity and receive text messages
* Physically mobile for duration of the trial
Exclusion Criteria
* Biological impairment or health condition affecting the ability to walk, such as blindness, physical immobility, and paralysis
* Pregnant or breastfeeding
* On insulin for diabetes control
30 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Grants Committee, Hong Kong
OTHER_GOV
The University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jianchao Quan, MPH, BM BCh
Role: PRINCIPAL_INVESTIGATOR
School of Public Health, The University of Hong Kong
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong
Hong Kong, , Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BET2-v4-202106
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.